The levels of serum miR-155 could reflect the effect of surgery and chemotherapy in breast cancer, whereas the conventional biomarkers, such as carcinoembryonic antigen (CEA) and tissue polypeptide-specific antigen (TPS), were not that sensitive (Sun et al., 2012). This evidence concerns the gene CEACAM5 and breast carcinoma.